STRIDES PHARMA SCIENCE LIMITED — Capital/Financing Update 2022

Feb 7, 2022

February 7, 2022

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Scrip Code: STAR

The BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001.

Scrip Code: 532531

Dear Madam/ Sir,

Sub: Fund raising - Intimation under Regulation 29(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“SEBI Listing Regulations").

We refer to our earlier intimation of January 27, 2022 regarding the Board Meeting of the Company rescheduled for February 10, 2022 to inter alia consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months ended December 31, 2021.

We now wish to inform you that at the meeting scheduled for February 10, 2022, the Board of Directors will also consider inter alia , a proposal for fund raising by way of issue of equity shares/ convertible warrants and/or any other instruments through preferential issue on a private placement basis, subject to such regulatory or statutory approvals as may be required and the approval of the shareholders of the Company.

Further, we wish to inform you that the Company proposes to seek Members’ approval for the said proposal in due course by way of Postal Ballot/ Extraordinary General Meeting.

We request you to kindly take this letter on record and disseminate on your website.

Thanks & Regards, For Strides Pharma Science Limited,

==> picture [115 x 52] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [85 x 83] intentionally omitted <==

==> picture [479 x 52] intentionally omitted <==